Nina Lin, MD
Assistant Professor
Boston University School of Medicine
Dept of Medicine
Infectious Diseases

MD, Harvard Medical School

Dr. Nina Lin is a physician scientist who is engaged in HIV translational research. Her research is focused on understanding the effect of chronic HIV infection on aging of the immune system and chronic inflammation. She is the PI on several clinical trials, including being a co-Chair of ACTG A5325 and A5220s, to evaluate interventions which may improve or alter the clinical course of chronic HIV infection. Her research while at MGH/BWH had been on understanding HIV-1 coreceptor usage in subtype C infection and the factors associated with its switching. She is the Director of the BU Infectious Disease Clinical Research Unit (CRU) where several HIV and/or infectious diseases clinical studies are being conducted.

Impact of smoking and its cessation on systemic and airway immune activation
08/15/2016 - 06/30/2018 (Co-Investigator)
Boston Medical Center Corporation NIH NIDA

Providence/Boston Center for AIDS Research(CFAR): Core E-Biobehavioral Sciences
07/01/2018 - 06/30/2023 (PI)
Miriam Hospital NIH-NIAID

06/28/2020 - 06/28/2023 (PI)

Tocilizumab to Prevent the Progression of Hypoxemic Respiratory Failure in Hospitalized…
04/30/2020 - 04/30/2023 (PI)
Mass General Hosp Genentech

Persistent HIV expression induced type 1 IFN responses and inflammaging
08/01/2018 - 04/30/2023 (PI)
Trustees of Boston University NIH-NIAID

SALSA 208090 A Phase III, randomized, multicenter, open-label, non-inferiority study evaluating…
03/06/2020 - 03/05/2023 (PI)
ViiV Healthcare

Rapid Bacterial Identification (RABIT) Study
08/01/2019 - 08/31/2022 (PI)
Day Zero Diagnostics, Inc.

Impact of smoking and its cessation on systemic and airway immune activation
08/15/2016 - 06/30/2022 (PI)

GS-US-380-4580 A Phase 3b, Multicenter, Open-Label Study to Evaluate Switching From a Regimen of…
01/01/2019 - 01/31/2022 (PI)
Gilead Sciences

01/01/2019 - 01/31/2022 (PI)
Brigham & Women's

The Effects of Opiod Use on HIV-1 Reservoir Dynamics
08/15/2018 - 05/31/2021 (PI)
Brigham & Women's NIH-NIDA

Showing 10 of 28 results. Show All Results


Yr Title Project-Sub Proj Pubs
2021 Persistent HIV expression induced type I IFN responses and inflammaging 5R01AG060890-04 2
2021 Impact of smoking and its cessation on systemic and airway immune activation 5R01DA042685-05
2020 The effects of opioid use on HIV-1 reservoir dynamics 5R61DA047038-03
2020 Persistent HIV expression induced type I IFN responses and inflammaging 5R01AG060890-03 2
2020 Impact of smoking and its cessation on systemic and airway immune activation 5R01DA042685-04
2019 The effects of opioid use on HIV-1 reservoir dynamics 5R61DA047038-02
2019 Persistent HIV expression induced type I IFN responses and inflammaging 5R01AG060890-02 2
2019 Impact of smoking and its cessation on systemic and airway immune activation 5R01DA042685-03
2018 The effects of opioid use on HIV-1 reservoir dynamics 1R61DA047038-01
2018 Persistent HIV expression induced type I IFN responses and inflammaging 1R01AG060890-01 2
Showing 10 of 18 results. Show All Results

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Olson A, Coote C, Snyder-Cappione JE, Lin N, Sagar M. HIV-1 Transcription but Not Intact Provirus Levels are Associated With Systemic Inflammation. J Infect Dis. 2021 Jun 04; 223(11):1934-1942.View Related Profiles. PMID: 33075121; PMCID: PMC8176637; DOI: 10.1093/infdis/jiaa657;
  2. Kamel MH, Mahmoud H, Zhen A, Liu J, Bielick CG, Mostaghim A, Lin N, Chitalia V, Ilori T, Waikar SS, Upadhyay A. End-stage kidney disease and COVID-19 in an urban safety-net hospital in Boston, Massachusetts. PLoS One. 2021; 16(6):e0252679.View Related Profiles. PMID: 34086775; PMCID: PMC8177422; DOI: 10.1371/journal.pone.0252679;
  3. Yuen RR, Steiner D, Pihl RMF, Chavez E, Olson A, Smith EL, Baird LA, Korkmaz F, Urick P, Sagar M, Berrigan JL, Gummuluru S, Corley RB, Quillen K, Belkina AC, Mostoslavsky G, Rifkin IR, Kataria Y, Cappione AJ, Gao W, Lin NH, Bhadelia N, Snyder-Cappione JE. Novel ELISA Protocol Links Pre-Existing SARS-CoV-2 Reactive Antibodies With Endemic Coronavirus Immunity and Age and Reveals Improved Serologic Identification of Acute COVID-19 via Multi-Parameter Detection. Front Immunol. 2021; 12:614676.View Related Profiles. PMID: 33897682; PMCID: PMC8062931; DOI: 10.3389/fimmu.2021.614676;
  4. Stone JH, Frigault MJ, Serling-Boyd NJ, Fernandes AD, Harvey L, Foulkes AS, Horick NK, Healy BC, Shah R, Bensaci AM, Woolley AE, Nikiforow S, Lin N, Sagar M, Schrager H, Huckins DS, Axelrod M, Pincus MD, Fleisher J, Sacks CA, Dougan M, North CM, Halvorsen YD, Thurber TK, Dagher Z, Scherer A, Wallwork RS, Kim AY, Schoenfeld S, Sen P, Neilan TG, Perugino CA, Unizony SH, Collier DS, Matza MA, Yinh JM, Bowman KA, Meyerowitz E, Zafar A, Drobni ZD, Bolster MB, Kohler M, D'Silva KM, Dau J, Lockwood MM, Cubbison C, Weber BN, Mansour MK. Efficacy of Tocilizumab in Patients Hospitalized with Covid-19. N Engl J Med. 2020 12 10; 383(24):2333-2344.View Related Profiles. PMID: 33085857; PMCID: PMC7646626; DOI: 10.1056/NEJMoa2028836;
  5. Sinha P, Mostaghim A, Bielick CG, McLaughlin A, Hamer DH, Wetzler LM, Bhadelia N, Fagan MA, Linas BP, Assoumou SA, Ieong MH, Lin NH, Cooper ER, Brade KD, White LF, Barlam TF, Sagar M. Early administration of interleukin-6 inhibitors for patients with severe COVID-19 disease is associated with decreased intubation, reduced mortality, and increased discharge. Int J Infect Dis. 2020 Oct; 99:28-33.View Related Profiles. PMID: 32721528; PMCID: PMC7591937; DOI: 10.1016/j.ijid.2020.07.023;
  6. Registre L, Moreau Y, Ataca ST, Pulukuri S, Henrich TJ, Lin N, Sagar M. HIV-1 Coreceptor Usage and Variable Loop Contact Impact V3 Loop Broadly Neutralizing Antibody Susceptibility. J Virol. 2020 01 06; 94(2).View Related Profiles. PMID: 31694950; PMCID: PMC6955257; DOI: 10.1128/JVI.01604-19;
  7. Asundi A, Cervantes-Arslanian AM, Lin NH, Barbosa F. Infectious Myelitis. Semin Neurol. 2019 08; 39(4):472-481.View Related Profiles. PMID: 31533188
  8. Asundi A, Robles Y, Starr T, Landay A, Kinslow J, Ladner J, White L, Plank RM, Melbourne K, Weisholtz D, Bennett M, Pan H, Stern E, Lin A, Kuritzkes DR, Lin NH. Immunological and Neurometabolite Changes Associated With Switch From Efavirenz to an Integrase Inhibitor. J Acquir Immune Defic Syndr. 2019 08 15; 81(5):585-593.View Related Profiles. PMID: 31045650; PMCID: PMC6625862; DOI: 10.1097/QAI.0000000000002079;
  9. Belkina AC, Starchenko A, Drake KA, Proctor EA, Pihl RMF, Olson A, Lauffenburger DA, Lin N, Snyder-Cappione JE. Multivariate Computational Analysis of Gamma Delta T Cell Inhibitory Receptor Signatures Reveals the Divergence of Healthy and ART-Suppressed HIV+ Aging. Front Immunol. 2018; 9:2783.View Related Profiles. PMID: 30568654; PMCID: PMC6290897; DOI: 10.3389/fimmu.2018.02783;
  10. Olson A, Ragan EJ, Nakiyingi L, Lin N, Jacobson KR, Ellner JJ, Manabe YC, Sagar M. Brief Report: Pulmonary Tuberculosis Is Associated With Persistent Systemic Inflammation and Decreased HIV-1 Reservoir Markers in Coinfected Ugandans. J Acquir Immune Defic Syndr. 2018 11 01; 79(3):407-411.View Related Profiles. PMID: 30063648; PMCID: PMC6506856; DOI: 10.1097/QAI.0000000000001823;
Showing 10 of 27 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 23 publications over 14 distinct years, with a maximum of 3 publications in 2020 and 2021

Contact for Mentoring:

650 Albany St Evans Biomed Research Ctr
Boston MA 02118
Google Map

Lin's Networks
Click the "See All" links for more information and interactive visualizations
Media Mentions
Similar People
Same Department